This article reviews the main prognostic and predictive biomarkers of endometrial (EC) and
ovarian carcinoma (OC). In EC, prognosis still relies on conventional pathological features …

In spite of the high and increasing incidence of endometrial cancer, our current models for
prediction of prognosis and even more treatment response are suboptimal, and molecular …

Endometrial carcinoma is the most common malignancy in the female genital system and
has increased in incidence during the past years. Our study was retrospective and included …

Objective The role of clinicopathological factors and molecular markers in prognostic
classification of endometrioid ovarian carcinoma (EnOC) is not established. Tumor grade is …

Endometrial cancer (EC) is the sixth most common cancer in women worldwide and its
mortality is directly associated with the presence of poor prognostic factors driving tumor …

Endometrial cancer is the most common gynecologic malignancy in more developed
countries. Approximately 75% of cases are diagnosed at an early stage with a tumor …

Although endometrial carcinoma (EC) is generally considered to have a good prognosis,
over 20% of women with EC die of their disease, with a projected increase in both incidence …

FIGO stage, tumor grade, depth of myometrial invasion, lymph-vascular space status and
lymph node status are the most important clinical-pathological prognostic variables for …

Endometrial adenocarcinoma is the most common malignant neoplasm of the female genital
tract and, despite its relative frc-quency, the molecular events that contribute to the …

Objective: The objectives of this study were to assess the immunohistochemical expression
of p53, bcl-2, c-erbB-2, Ki-67, estrogen (ER) and progesterone (PR) receptors, matrix …